The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Review and Comparison to the Papanicolaou Society of Cytopathology System
- PMID: 38190275
- DOI: 10.5858/arpa.2023-0411-RA
The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Review and Comparison to the Papanicolaou Society of Cytopathology System
Abstract
Context.—: The World Health Organization (WHO) Reporting System for Pancreaticobiliary Cytopathology (WHO System) is the product of a joint venture between the World Health Organization, the International Academy of Cytology, and the International Agency for Research on Cancer. The WHO System revises the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology (PSC System) and replaces the 6-tiered system with a 7-tiered system.
Objective.—: To explain the WHO System and the differences with the PSC System.
Data sources.—: The WHO System and the PSC System of Reporting Pancreaticobiliary Cytopathology.
Conclusions.—: The diagnostic categories of the WHO System are "Insufficient/Inadequate/Nondiagnostic"; "Benign (Negative for Malignancy)"; "Atypical"; "Pancreaticobiliary Neoplasm, Low Risk/Low Grade (PaN-Low)"; "Pancreatic Neoplasm, High Risk/High Grade (PaN-High)"; "Suspicious for Malignancy"; and "Malignant." In the WHO System, the "benign" category includes both nonneoplastic and neoplastic lesions, so the "Neoplastic: Benign" category of the PSC system has been eliminated. Low-grade malignancies, pancreatic neuroendocrine tumors (PanNETs), and solid-pseudopapillary neoplasm (SPN) classified as "Neoplastic: Other" in the PSC System are classified as "Malignant" in the WHO System, leaving in the "Neoplasm" category intraductal lesions, which are divided into 2 new diagnostic categories: "Pancreaticobiliary Neoplasm (PaN)-Low Risk/Grade" and "PaN-High Risk/Grade." As with the PSC System, the WHO System advocates close correlation with imaging and encourages incorporation of ancillary testing into the final diagnosis, such as biochemical (carcinoembryonic antigen [CEA] and amylase) and molecular testing. The WHO System includes risk of malignancy per category, and reporting and diagnostic management options that recognize the variations in resources of low- and middle-income countries.
© 2025 College of American Pathologists.
Conflict of interest statement
The author has no relevant financial interest in the products or companies described in this article.
Similar articles
-
The World Health Organization Reporting System for Pancreaticobiliary Cytopathology.Acta Cytol. 2023;67(3):304-320. doi: 10.1159/000527912. Epub 2022 Dec 14. Acta Cytol. 2023. PMID: 36516741 Review.
-
A brief review of the WHO reporting system for pancreaticobiliary cytopathology.J Am Soc Cytopathol. 2023 Jul-Aug;12(4):243-250. doi: 10.1016/j.jasc.2023.03.002. Epub 2023 Mar 7. J Am Soc Cytopathol. 2023. PMID: 37003924 Review.
-
Risk of malignancy and overall survival associated with the diagnostic categories in the World Health Organization Reporting System for Pancreaticobiliary Cytopathology.Cancer Cytopathol. 2024 Oct;132(10):635-645. doi: 10.1002/cncy.22880. Epub 2024 Jun 30. Cancer Cytopathol. 2024. PMID: 38944695
-
The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary.Cancer Cytopathol. 2024 Jul;132(7):396-418. doi: 10.1002/cncy.22806. Epub 2024 May 6. Cancer Cytopathol. 2024. PMID: 38709670 Review.
-
Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.Cancer Cytopathol. 2022 Mar;130(3):195-201. doi: 10.1002/cncy.22514. Epub 2021 Oct 8. Cancer Cytopathol. 2022. PMID: 34623767
Cited by
-
The nomograph predicting the recurrence of Solid Pseudopapillary Neoplasm of the Pancreas: a study of the SEER database and a Chinese cohort.BMC Gastroenterol. 2025 Jul 1;25(1):482. doi: 10.1186/s12876-025-04076-7. BMC Gastroenterol. 2025. PMID: 40597670 Free PMC article.
-
Comprehensive analysis of pancreatic fine needle aspiration cyto-histopathological correlation.Cytojournal. 2025 May 9;22:50. doi: 10.25259/Cytojournal_218_2024. eCollection 2025. Cytojournal. 2025. PMID: 40539125 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials